SPL 3.13% 9.9¢ starpharma holdings limited

Has the seling dried up, page-19

  1. 3,456 Posts.
    lightbulb Created with Sketch. 823
    FDA QIDP and Fast Track designations are pointless and irrelevant if one’s Phase 3 trial results are not clear, unambiguous and overwhelmingly positive.
    End of story.
    Last edited by sarge17: 20/02/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.